IMO Health is pleased to announce the launch of a comprehensive suite of clinical trial enablement solutions, designed specifically for life sciences and clinical contract research organizations (CCROs). This offering addresses the escalating challenges of site performance and patient recruitment by delivering real-time, electronic health record (EHR)-integrated intelligence powered by IMO Health’s proprietary terminology, used by 90% of healthcare providers across the United States daily.
CROs and sponsors often grapple with multi-site, multi-therapeutic area trials, data fragmentation, and persistent recruitment challenges. IMO Health addresses these challenges by delivering unprecedented precision in site selection, activation, patient identification, and trial result collection – enabling faster, more efficient, and higher-quality clinical trials.
IMO Health enables:
- Site selection: Leverages widely embedded IMO Health terminology to accurately assess site feasibility, strengthen response for proposal (RFP) responses, and eliminate costly non-performing sites before activation. With protocol-aligned patient counts and normalized EHR data replacing lagging, claims-based assumptions, sponsors gain faster, more confident go/no-go decisions. At the same time, CROs can demonstrate a clear ability to deliver on enrollment commitments.
- Site activation: Enables rapid, plug-and-play integration with minimal IT involvement through EHR-native flat files and embedded workflow alerts for patient identification and pre-screening. Start-up times can be accelerated by up to two months, with clinical research coordinators (CRCs) leveraging in-workflow lists to identify pre-screened, trial-eligible patients and minimize workflow disruption.
- Patient identification: Enables precision cohorting using IMO Health’s clinically nuanced terminology to reduce screen failures and false positives by up to 99%, while cutting CRCs’ manual chart review burden by as much as 98% –resulting in optimized pre-screening and faster, more efficient trial enrollment.
- Trial result collection: Enables automated extraction of trial endpoints and adverse events from unstructured clinical notes, with direct EHR-to-electronic data capture (EDC) transmission. This innovation reduces manual transcription errors, enhances data integrity, and accelerates database lock.
With decades as the clinical terminology backbone of U.S. healthcare, IMO Health brings sponsors and CROs a unique advantage through real-time, protocol-ready clinical intelligence rooted in actual provider documentation. By standardizing EHR data and enriching claims with real-world provider behavior, we enable faster, more confident trial decisions, from site selection to patient recruitment, solving persistent challenges like patient identification, underperforming sites, and enrollment delays.
Why CROs choose IMO Health:
- The industry’s most granular proprietary clinical terminology in patient identification
- Fully EHR-native cohorting, accelerating precision recruitment
- Rapid deployment across sites with minimal IT burden
- Automated, structured trial endpoint data captured directly from clinical notes
- Deep semantic normalization ensuring data fidelity across real-world data assets
By tapping into the clinical moment, IMO Health transforms clinical trial operations; finding the right patients faster, reducing costly trial delays, and enabling sponsors to bring therapies to market more efficiently.
